Cargando…

Natural Killer Cell Mediated Missing-Self Recognition Can Protect Mice from Primary Chronic Myeloid Leukemia In Vivo

BACKGROUND: Natural Killer (NK) cells are thought to protect from residual leukemic cells in patients receiving stem cell transplantation. However, multiple retrospective analyses of patient data have yielded conflicting conclusions regarding a putative role of NK cells and the essential NK cell rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kijima, Mika, Gardiol, Noémie, Held, Werner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223190/ https://www.ncbi.nlm.nih.gov/pubmed/22132120 http://dx.doi.org/10.1371/journal.pone.0027639

Ejemplares similares

Cytomegalovirus immunoevasin reveals the physiological role of “missing self” recognition in natural killer cell dependent virus control in vivo
por: Babić, Marina, et al.
Publicado: (2010)

The role of natural killer cells in chronic myeloid leukemia
por: Danier, Anna Carolyna Araújo, et al.
Publicado: (2011)

Natural killer cell-based immunotherapy for acute myeloid leukemia
por: Xu, Jing, et al.
Publicado: (2020)

Clinical Impact of Percentage of Natural Killer Cells and Natural Killer-Like T Cell Population in Acute Myeloid Leukemia
por: Jamal, Esraa, et al.
Publicado: (2020)

Macrophages protect mycoplasma‐infected chronic myeloid leukemia cells from natural killer cell killing
por: Choo, Qing Wei Winnie, et al.
Publicado: (2020)

Prognostically relevant natural killer cell-mediated immunoediting in acute myeloid leukemia
por: Chan, Christopher J, et al.
Publicado: (2013)

Interactions of Human Myeloid Cells with Natural Killer Cell Subsets In Vitro and In Vivo
por: Chijioke, Obinna, et al.
Publicado: (2011)

The More, The Better: “Do the Right Thing” For Natural Killer Immunotherapy in Acute Myeloid Leukemia
por: Parisi, Sarah, et al.
Publicado: (2017)

Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia
por: Martner, Anna, et al.
Publicado: (2015)

Adaptations of Natural Killer Cells to Self-MHC Class I
por: Bessoles, Stéphanie, et al.
Publicado: (2014)

Calreticulin mediates immune recognition of acute myeloid leukemia cells in vivo
por: Chen, Xiufen, et al.
Publicado: (2013)

Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells
por: Dulphy, Nicolas, et al.
Publicado: (2016)

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

Acute Myeloid Leukemia Epigenetic Immune Escape From Nature Killer Cells by ICAM-1
por: Xiao, Yang, et al.
Publicado: (2021)

PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia
por: Li, Jessica, et al.
Publicado: (2020)

Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Cianga, Vlad Andrei, et al.
Publicado: (2021)

Activation by SLAM Family Receptors Contributes to NK Cell Mediated “Missing-Self” Recognition
por: Alari-Pahissa, Elisenda, et al.
Publicado: (2016)

Natural killer T cell recognition of lipid antigens
por: Teyton, Luc
Publicado: (2009)

Recognition of Microbial Glycolipids by Natural Killer T Cells
por: Zajonc, Dirk M., et al.
Publicado: (2015)

Protective HLA-B57: T cell and natural killer cell recognition in HIV infection
por: Lobos, Christian A., et al.
Publicado: (2022)

Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han
por: Deng, Zhihui, et al.
Publicado: (2019)

Natural Killer Cell-Mediated Immunotherapy for Leukemia
por: Allison, Michaela, et al.
Publicado: (2022)

Recognition of Lyso-Phospholipids by Human Natural Killer T Lymphocytes
por: Fox, Lisa M., et al.
Publicado: (2009)

Natural Killer Cell Recognition and Control of Epithelial Cancers
por: de Souza Fernandez Pereira, Marcelo, et al.
Publicado: (2022)

Secreted β(3)-Integrin Enhances Natural Killer Cell Activity against Acute Myeloid Leukemia Cells
por: Skaik, Younis, et al.
Publicado: (2014)

Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy
por: Ruggeri, Loredana, et al.
Publicado: (2015)

Sjögren's Syndrome Complicated by Myeloid/Natural Killer Cell Precursor Acute Leukemia: Case Report and Review of the Literature
por: Feng, Hao, et al.
Publicado: (2016)

Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia
por: Kulkarni, Uday, et al.
Publicado: (2023)

Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response
por: Cianga, Vlad Andrei, et al.
Publicado: (2023)

Bone marrow infiltrated natural killer cells predicted the anti-leukemia activity of MCL1 or BCL2 inhibitors in acute myeloid leukemia
por: Dai, Yu-Jun, et al.
Publicado: (2021)

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients
por: Truxova, Iva, et al.
Publicado: (2020)

Peptides Targeting Fms-Related Tyrosine Kinase-4 Activate the Function of Natural Killer Cells in Acute Myeloid Leukemia
por: Park, Soojin, et al.
Publicado: (2021)

Off-the-shelf CAR–engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia
por: Mansour, Anthony G., et al.
Publicado: (2023)

Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients
por: Ahmadvand, Mohammad, et al.
Publicado: (2023)

Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge
por: You, Eunkyoung, et al.
Publicado: (2023)

The Structural Basis of Ligand Recognition by Natural Killer Cell Receptors
por: Joyce, M. Gordon, et al.
Publicado: (2011)

Adenovirus vector delivery stimulates natural killer cell recognition
por: Tomasec, Peter, et al.
Publicado: (2007)

Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
por: Gaggero, Silvia, et al.
Publicado: (2021)

Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial
por: Kottaridis, Panagiotis D., et al.
Publicado: (2015)

Natural Killer Immunotherapy for Minimal Residual Disease Eradication Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
por: Hattori, Norimichi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nlssgdenknseea2qcntkm75cll